Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIPEC With Carboplatin in Elderly and Frail Ovarian Cancer Patients
NCT07733505Phase 1Recruiting
- Sponsor
- University Hospital Odense
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of carboplatin in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC), sponsored by University Hospital Odense. Primary endpoint: Proportion of Participants with Treatment-Related Adverse Events and Adverse Reactions. Started Jun 2026; status: recruiting.
02
Drugs
carboplatin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT07733505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07733505.